LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Lifecore Biomedical, Inc. \De\ quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2010 to Q3 2024.
  • Lifecore Biomedical, Inc. \De\ Weighted Average Number of Shares Outstanding, Basic for the quarter ending August 25, 2024 was 30.9M shares, a 1.49% increase year-over-year.
  • Lifecore Biomedical, Inc. \De\ annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 30.5M shares, a 1.72% increase from 2022.
  • Lifecore Biomedical, Inc. \De\ annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 30M shares, a 1.67% increase from 2021.
  • Lifecore Biomedical, Inc. \De\ annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 29.5M shares, a 0.59% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 30.9M +452K +1.49% May 27, 2024 Aug 25, 2024 10-Q 2024-10-04
Q2 2024 30.5M +516K +1.72% Feb 26, 2024 May 26, 2024 10-K 2024-08-26
Q1 2024 30.5M +184K +0.61% Nov 27, 2023 Feb 25, 2024 10-Q 2024-08-09
Q4 2023 30.5M +824K +2.78% Aug 28, 2023 Nov 26, 2023 10-Q 2024-08-09
Q3 2023 30.4M +826K +2.79% May 29, 2023 Aug 27, 2023 10-Q 2024-10-04
Q2 2023 30M +492K +1.67% Feb 27, 2023 May 28, 2023 10-K 2024-08-26
Q1 2023 30.3M +822K +2.79% Nov 28, 2022 Feb 26, 2023 10-Q 2024-08-09
Q4 2022 29.6M +163K +0.55% Aug 29, 2022 Nov 27, 2022 10-Q 2024-08-09
Q3 2022 29.6M +153K +0.52% May 30, 2022 Aug 28, 2022 10-Q 2024-08-09
Q2 2022 29.5M +172K +0.59% Feb 28, 2022 May 29, 2022 10-K 2024-08-26
Q1 2022 29.5M +159K +0.54% Nov 29, 2021 Feb 27, 2022 10-K 2024-03-20
Q4 2021 29.5M +191K +0.65% Aug 30, 2021 Nov 28, 2021 10-K 2024-03-20
Q3 2021 29.4M +182K +0.62% May 31, 2021 Aug 29, 2021 10-K 2024-03-20
Q2 2021 29.3M +132K +0.45% Mar 1, 2021 May 30, 2021 10-K 2024-03-20
Q1 2021 29.3M +153K +0.53% Nov 30, 2020 Feb 28, 2021 10-K 2024-03-20
Q4 2020 29.3M +125K +0.43% Aug 31, 2020 Nov 29, 2020 10-K 2024-03-20
Q3 2020 29.2M +103K +0.35% Jun 1, 2020 Aug 30, 2020 10-K 2024-03-20
Q2 2020 29.2M +803K +2.83% Feb 24, 2020 May 31, 2020 10-K/A 2023-03-16
Q1 2020 29.2M +251K +0.87% Nov 25, 2019 Feb 23, 2020 10-Q 2021-04-08
Q4 2019 29.2M +1.39M +5.01% Aug 26, 2019 Nov 24, 2019 10-Q 2021-01-07
Q3 2019 29.1M +1.4M +5.05% May 27, 2019 Aug 25, 2019 10-Q 2020-10-07
Q2 2019 28.4M +824K +2.99% Feb 25, 2019 May 26, 2019 10-K 2021-07-29
Q1 2019 28.9M +1.37M +4.98% Nov 26, 2018 Feb 24, 2019 10-Q 2020-04-03
Q4 2018 27.8M +246K +0.89% Aug 27, 2018 Nov 25, 2018 10-Q 2020-01-02
Q3 2018 27.7M +232K +0.84% May 28, 2018 Aug 26, 2018 10-Q 2019-10-03
Q2 2018 27.5M +259K +0.95% Feb 26, 2018 May 27, 2018 10-K 2020-08-14
Q1 2018 27.5M +261K +0.96% Nov 27, 2017 Feb 25, 2018 10-Q 2019-04-04
Q4 2017 27.5M +269K +0.99% Aug 28, 2017 Nov 26, 2017 10-Q 2019-01-07
Q3 2017 27.5M +287K +1.05% May 29, 2017 Aug 27, 2017 10-Q 2018-10-05
Q2 2017 27.3M +232K +0.86% Feb 27, 2017 May 28, 2017 10-K 2019-08-01
Q1 2017 27.3M +232K +0.86% Nov 28, 2016 Feb 26, 2017 10-Q 2018-04-05
Q4 2016 27.2M +228K +0.84% Aug 29, 2016 Nov 27, 2016 10-Q 2018-01-05
Q3 2016 27.2M +214K +0.79% May 30, 2016 Aug 28, 2016 10-Q 2017-09-28
Q2 2016 27M +160K +0.6% Feb 29, 2016 May 29, 2016 10-K 2018-08-09
Q1 2016 27.1M +168K +0.63% Nov 30, 2015 Feb 28, 2016 10-Q 2017-04-07
Q4 2015 27M +157K +0.58% Aug 31, 2015 Nov 29, 2015 10-Q 2017-01-05
Q3 2015 27M +165K +0.62% Jun 1, 2015 Aug 30, 2015 10-Q 2016-09-29
Q2 2015 26.9M +256K +0.96% Mar 2, 2015 May 31, 2015 10-K/A 2018-03-15
Q1 2015 26.9M +189K +0.71% Dec 1, 2014 Mar 1, 2015 10-Q 2016-03-30
Q4 2014 26.9M +293K +1.1% Sep 1, 2014 Nov 30, 2014 10-Q 2016-01-07
Q3 2014 26.8M +388K +1.47% Jun 2, 2014 Aug 31, 2014 10-Q 2015-10-01
Q2 2014 26.6M +798K +3.09% Feb 24, 2014 May 25, 2014 10-K 2016-08-01
Q1 2014 26.7M +858K +3.32% Nov 25, 2013 Feb 23, 2014 10-Q 2015-04-02
Q4 2013 26.6M +824K +3.2% Aug 26, 2013 Nov 24, 2013 10-Q 2015-01-09
Q3 2013 26.5M +782K +3.05% May 27, 2013 Aug 25, 2013 10-Q 2014-10-08
Q2 2013 25.8M -19K -0.07% Feb 25, 2013 May 26, 2013 10-K 2015-07-31
Q1 2013 25.8M +301K +1.18% Nov 26, 2012 Feb 24, 2013 10-Q 2014-03-28
Q4 2012 25.7M -138K -0.53% Aug 27, 2012 Nov 25, 2012 10-Q 2014-01-03
Q3 2012 25.7M -739K -2.8% May 28, 2012 Aug 26, 2012 10-Q 2013-09-26
Q2 2012 25.8M -548K -2.08% Feb 27, 2012 May 27, 2012 10-K 2014-08-01
Q1 2012 25.5M -837K -3.17% Nov 28, 2011 Feb 26, 2012 10-Q 2013-04-04
Q4 2011 25.9M -439K -1.67% Aug 29, 2011 Nov 27, 2011 10-Q 2013-01-04
Q3 2011 26.4M -91K -0.34% May 28, 2011 Aug 28, 2011 10-Q/A 2013-01-02
Q2 2011 26.4M Feb 28, 2011 May 29, 2011 10-K 2013-08-07
Q1 2011 26.4M Nov 29, 2010 Feb 27, 2011 10-Q 2012-03-28
Q4 2010 26.3M Aug 30, 2010 Nov 28, 2010 10-Q 2012-01-05
Q3 2010 26.5M Jun 1, 2010 Aug 29, 2010 10-Q 2011-10-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.